For the Inventor, By the Inventor

Enter assignee name

West Chester, PA, United States of America

Cephalon, Inc.

USPTO Granted Patents = 247

CIPO Patents = 7

EPO Patents = 53

Trademarks = 17

Forward Citations = 2,259

Loading Chart...

Loading Chart...

278 inventors (with patents filed for the assignee):

Robert L Hudkins (53 out of 72 patents)

Sankar Chatterjee (40 out of 42 patents)

John P Mallamo (23 out of 43 patents)

4. Rabindranath Tripathy (19 out of 24 patents)

5. Edward R Bacon (19 out of 64 patents)

6. Derek D Dunn (19 out of 19 patents)

7. Allison L Zulli (16 out of 29 patents)

8. Michael E Lewis (16 out of 20 patents)

9. Mohamed A Iqbal (16 out of 17 patents)

10. Ming Tao (15 out of 23 patents)

11. Piyush R Patel (15 out of 20 patents)

12. Diane E Gingrich (15 out of 16 patents)

13. Nadine C Becknell (14 out of 20 patents)

14. Laurent D Courvoisier (14 out of 16 patents)

15. James C Kauer (14 out of 20 patents)

Core Competencies:

Spiropiperidine Derivatives

Anti-PAR-2 Antibodies

Polynucleotides Encoding Antibodies

Anti-CXCR2 Antibodies

Fused Bicyclic Derivatives

Nanoparticulate Formulations

Crystalline Forms of PARP Inhibitors

Janus Kinase Inhibitors

Immunoconjugates

Pharmaceutical Prodrugs

Anti-IL-5 Antibodies

Bendamustine Compositions

247 patents: Sort by Forward Citations

1. 12448392 - Spiropiperidine derivatives (2025-10-21),

2. 12441702 - Substituted 4-benzyl and 4-benzoyl piperidine derivates (2025-10-14),

3. 12410256 - Antibodies that specifically bind to TL1a and methods of treating gastrointestinal or lung diseases (2025-09-09),

4. 12410247 - Polynucleotides encoding antibodies that specifically bind to human IL-15 (2025-09-09),

5. 12384841 - Anti-PAR-2 antibodies and methods of use thereof (2025-08-12),

6. 12358980 - Compositions and methods for anti-PACAP antibodies (2025-07-15),

7. 12281148 - Anti-pd-1 antibody-attenuated IL-2 immunoconjugates and uses thereof (2025-04-21),

8. 12162946 - Antibodies that specifically bind to TL1A and methods of treating gastrointestinal disease (2024-12-10),

9. 12018084 - Anti-CXCR2 antibodies and uses thereof (2024-06-25),

10. 11725052 - Anti-PAR-2 antibodies and methods of use thereof (2023-08-15),

11. 11426706 - Cation exchange chromatography wash buffer (2022-08-30),

12. 11332534 - Anti-CXCR2 antibodies and uses thereof (2022-05-17),

13. 11267883 - Antibodies that specifically bind to human IL-15 and uses thereof (2022-03-08),

14. 11224653 - Treatment strategy for non-responders to 100MG subcutaneous mepolizumab (2022-01-18),

15. 11220549 - Antibodies that specifically bind to TL1A and methods of treating respiratory tract diseases (2022-01-11),

Cephalon, Inc. is a pharmaceutical company specializing in the development and commercialization of innovative therapies to treat various diseases. With a focus on neurological disorders, cancer, and pain management, Cephalon aims to improve the lives of patients worldwide. Their website provides detailed information about their products, research, and commitment to advancing medical science.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 23 2025

247 Patents

#2 in West Chester, PA

#63 in Pennsylvania

#1,650 in US

#3,391 in the World

West Chester, PA, United States of America

Cephalon, Inc.

Forward Citations = 2,259

278 inventors:

Robert L Hudkins (53 out of 72 patents)

Sankar Chatterjee (40 out of 42 patents)

John P Mallamo (23 out of 43 patents)

4. Rabindranath Tripathy (19 out of 24 patents)

5. Edward R Bacon (19 out of 64 patents)

Please report any incorrect information to support@idiyas.com

Loading…